Scandinavia: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2024

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Scandinavia

The Scandinavia human and animal blood market reached $X in 2023, increasing by X% against the previous year. Over the period under review, consumption continues to indicate a strong increase. Over the period under review, the market hit record highs in 2023 and is expected to retain growth in the immediate term.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Scandinavia

In value terms, human and animal blood production declined markedly to $X in 2023 estimated in export price. Over the period under review, production posted resilient growth. The most prominent rate of growth was recorded in 2014 with an increase of X% against the previous year. The level of production peaked at $X in 2019; however, from 2020 to 2023, production stood at a somewhat lower figure.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in Scandinavia

In 2023, exports of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Scandinavia declined sharply to X tons, dropping by X% against 2022. In general, exports continue to indicate a drastic downturn. The pace of growth was the most pronounced in 2017 with an increase of X%. As a result, the exports reached the peak of X tons. From 2018 to 2023, the growth of the exports remained at a lower figure.

In value terms, human and animal blood exports dropped rapidly to $X in 2023. Overall, exports continue to indicate a abrupt curtailment. The growth pace was the most rapid in 2017 with an increase of X% against the previous year. As a result, the exports attained the peak of $X. From 2018 to 2023, the growth of the exports failed to regain momentum.

Exports by Country

In 2023, Norway (X tons) represented the key exporter of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, committing X% of total exports. It was distantly followed by Sweden (X tons), mixing up a X% share of total exports. Finland (X tons) took a minor share of total exports.

From 2012 to 2023, the most notable rate of growth in terms of shipments, amongst the main exporting countries, was attained by Norway (with a CAGR of X%), while the other leaders experienced a decline in the exports figures.

In value terms, Sweden ($X), Norway ($X) and Finland ($X) appeared to be the countries with the highest levels of exports in 2023.

Norway, with a CAGR of X%, saw the highest growth rate of the value of exports, among the main exporting countries over the period under review, while shipments for the other leaders experienced a decline in the exports figures.

Export Prices by Country

In 2023, the export price in Scandinavia amounted to $X per ton, waning by X% against the previous year. Export price indicated a moderate expansion from 2012 to 2023: its price increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2019 when the export price increased by X%. The level of export peaked at $X per ton in 2022, and then contracted rapidly in the following year.

There were significant differences in the average prices amongst the major exporting countries. In 2023, amid the top suppliers, the country with the highest price was Finland ($X per ton), while Norway ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Sweden (X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in Scandinavia

For the fourth year in a row, Scandinavia recorded growth in purchases abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, which increased by X% to X tons in 2023. Overall, imports enjoyed buoyant growth. The most prominent rate of growth was recorded in 2016 with an increase of X% against the previous year. The volume of import peaked in 2023 and is expected to retain growth in the immediate term.

In value terms, human and animal blood imports reached $X in 2023. Over the period under review, imports continue to indicate a prominent expansion. The most prominent rate of growth was recorded in 2016 when imports increased by X% against the previous year. The level of import peaked in 2023 and is expected to retain growth in the immediate term.

Imports by Country

Sweden dominates imports structure, finishing at X tons, which was near X% of total imports in 2023. Norway (X tons) followed a long way behind the leaders.

Sweden was also the fastest-growing in terms of the human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses imports, with a CAGR of X% from 2012 to 2023. Norway experienced a relatively flat trend pattern. While the share of Sweden (X p.p.) increased significantly in terms of the total imports from 2012-2023, the share of Norway (X p.p.) displayed negative dynamics.

In value terms, Sweden ($X) constitutes the largest market for imported human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Scandinavia, comprising X% of total imports. The second position in the ranking was taken by Norway ($X), with a X% share of total imports.

In Sweden, human and animal blood imports expanded at an average annual rate of X% over the period from 2012-2023.

Import Prices by Country

The import price in Scandinavia stood at $X per ton in 2023, reducing by X% against the previous year. Import price indicated a notable expansion from 2012 to 2023: its price increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, human and animal blood import price increased by X% against 2014 indices. The pace of growth appeared the most rapid in 2017 when the import price increased by X%. Over the period under review, import prices attained the peak figure at $X per ton in 2022, and then fell in the following year.

Average prices varied noticeably amongst the major importing countries. In 2023, amid the top importers, the country with the highest price was Sweden ($X per ton), while Norway amounted to $X per ton.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Sweden (X%).

Source: IndexBox Platform